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Summary Sex steroid receptor proteins were studied in human normal liver and hepatocellular carcinoma
(HCC). Oestrogen receptor (ER) was detected in nucleosol and cytosol of 4 normal adult and 5 malignant
liver specimens and in the cytosol of 6 foetal liver samples. Levels were 27.6-500 fmol mg 1 soluble protein in
normal adults (Kd 1.48 x l0-8-l.l2 x 1010moll-1), 45-290fmolmg-1 in malignant liver tissue (Kd
3.26x 10-9-3.64x 10-'moll-1) and a mean of 93fmolmg-1 in foetal tissue (Kd 1.55x lO-9moll-P).
Androgen receptors (AR) were found only in cytosol and nucleosol of HCC (23-370fmolmg-1) and in
cytosol from foetal liver (29fmolmg-1) with Kd from 2.90x l0-9 to 3.734x 1010moll-1. AR was
distinguished from sex hormone binding globulin, which was also present in all cytosol samples, by the
former's ability to selectively bind to methyltrienolone and the latter's absence from nucleosol. These findings
provide further support for suggestions that oestrogen-related hepatic functions in man may be mediated by
receptors and raise the possibility that hepatocellular carcinoma may be androgen dependent.
Mammalian liver is the major site of conversion
and catabolism of steroids and many of its
functions are known to be influenced by oestrogens
and androgens. In addition, hepatic adenoma
formation is known to be associated with oral
contraceptive usage (Klatskin, 1977), and there is
some evidence that hepatocellular carcinoma can
also develop (Neuberger et al., 1980), although
Goodman & Ishak (1982) failed to establish a
statistical relationship. The presence of oestrogen
receptors in non-human mammalian liver has been
shown by several groups of workers including
Eisenfeld et al. (1976), Aten et al. (1978), Danzo et
al. (1977) and Wrange et al. (1980). Duffy & Duffy
(1978) were the first to demonstrate ER in normal
human liver cytosol. Of further interest in relation
to tumour formation is their presence in hepatic
adenoma, demonstrated by McDonald et al. (1978),
and in HCC cytosol, shown by Molteni et al.
(1979) and Friedman et al. (1982). The latter
workers, however, showed no difference in ER
levels between HCC and surrounding normal liver
tissue.
Clinical studies have shown that in patients with
cirrhosis HCC develops about 10 times more
frequently in male than female patients (Peters,
1976) and that androgenic steroids have a
demonstrable malignant potential in the liver
(Johnson et al., 1972). Furthermore, direct effects
of androgens on protein regulation in the liver have
been shown by Chan et al. (1978) and others and
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liver microsomes was demonstrated by Yamada &
Majayi (1982), but it is widely believed that the
normal liver lacks androgen receptors and is not a
target organ for androgens (Anderson & Liao,
1968; Mainwaring, 1969; Ahmed, 1971).
In the present study we have investigated the
major sex steroid binding moieties in liver cytosol
and nucleosol from a variety of benign and
malignant human hepatic tissue. Foetal liver was
also studied because alphafoetoprotein (AFP)
synthesis occurs there as in HCC, and in work on
pancreatic tissue we had found ER in foetal tissue
and carcinoma but not in the normal adult organ
(Greenway et al., 1981).
Patients and methods
Samples of adult liver were obtained at operation
or at autopsy within 6h of death. Details of the 5
patients with malignant liver tumours are given in
Table I.
The normal adult liver samples, from two males
and two females aged 64, 40, 62 and 45 years
respectively, were obtained either at autopsy (n=2)
or at laparotomy (n=2), in one instance for
cholecystectomy when the biopsies proved
histologically normal and in the other when normal
liver tissue surrounding a cavernous haemangioma
in a female aged 45 was removed as part of the
resection. The haemangioma served as a non-
hepatocyte tissue control.
Foetal liver tissue was from foetuses of 12-18
weeks gestational age aborted using intrauterine
prostaglandin and obtained within 6h of delivery.
Pre-menopausal uterus and benign prostatic
hypertrophic tissue removed at operation were used
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Table I Clinical data ofpatients with malignant liver tumours
Previous Serum
liver Source of HBV AFP
Case Tumour Sex Age disease tissue markers ngml-1
1 HCC M 50 CAH Resection HBsAg 100,000
2 HCC M 42 None Transplant None 84,000
3 HCC F 18 None Autopsy None Negative
4 HCC M 60 CAH Resection HBcAg* 700
5 Hepato-
hb.atotma F 3/12 None Resection None 658,000
*This patient had integrated HBV DNA in the tumour.
CAH Chronic active hepatitis.
HBV Hepatitis B virus.
HBsAg Hepatitis B surface antigen.
HBcAg Hepatitis B core antigen.
as positive controls for ER and AR assays
respectively. All samples were stored at -176°C
until assayed.
Estimation ofandrogen and oestrogen receptors
Cytosol and nucleosol fractions were prepared as
previously described (Greenway et al., 1981), and
the original tissue weight:volume was 1:6 in the
incubates. Tissue samples were manipulated below
4°C and homogenised in TED buffer (1Ommol Tris,
1.5mM EDTA and 1 mM dithiothreitol, pH 7.4)
using an Ultra-Turrax homogeniser before
centrifugation at 160,000g for 1 h. The supernatant
was retained as cytosol. The pellet remaining when
the cytosol was decanted was washed in TES buffer
(IOmM Tris, 1 mM EDTA and 250mM sucrose,
pH 7.4), centrifuged at 800g for 10min, and the
supernatant discarded. The remaining pellet was
homogenised in TSMK buffer (1OmM Tris,
250mM sucrose, 5mM MgCl2 and 25mM KCI, pH
7.5) before filtration through a cellulose acetate
plug, centrifuged for 15min at 800g and the
supernatant discarded. The pellet was washed twice
in TSMK buffer and then resuspended in TKED
buffer containing 0.5mM KCI. The suspension was
kept at 4°C for 1 h and then centrifuged for 40min
at 15,000g, the supernatant being retained as
nucleosol. Samples were treated for the removal of
endogenous steroids with dextran coated charcoal
(DCC) (0.25% charcoal coated with 0.025%
Dextran T70, Pharmacia GB Ltd). The charcoal
was removed by centrifugation at 1200g for 20min
at 4°C. ER assay was carried out as described
(Greenway et al., 1981). In the AR assay the
synthetic steroid methyltrienolone, R1881 (specific
activity 87CimM-1), was used as the binding
ligand in the presence of a 200-fold excess of
triamcinolone acetonide to saturate the
progesterone receptor. In both assays the method of
Ginsburg et al. (1974) was used to separate bound
from free steroid. A Hewlett-Packard scintillation
counter (efficiency 40%) was used in all
experiments. Data were analysed by Scatchard
plots, with resolution of curvilinear plots by the
method ofChamness & McGuire (1975).
Estimation of binding to sex hormone binding
globulin andhuman serum albumin
Binding parameters of HSA and SHBG were
determined by the two-tier column method of Iqbal
& Johnson (1977). In preparations of cytosol and
nucleosol the receptor proteins were selectively
denatured as described previously (Greenway et al.,
1981).
Portions (0.4ml) of samples diluted to 1:30
original tissue wt: volume were then incubated with
increasing amounts (0-68.9pmol) of dihydrotesto-
sterone (DHT) in the presence of a constant
amount of 3H-DHT (specific activity 122CimM-1,
Amersham International) for 45min at 40C. The
radioactivity of the column eluates was determined
for the estimation of SHBG. The columns were
then cut at the interface of the two gels and the
radioactivity in the Blue gel (Cibacron Blue 3GA-
Sepharose 6B) was determined. The data were
analysed by Scatchard plots.
Results
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Table II Oestrogen receptor (ER) androgen receptor (AR) and dissociation constant (Kd) in foetal, adult and
malignant liver samples
ER AR SHBG
nmol DHT
Units:fmolmg 1 protein, kd in parenthesis bound 1-
Liver tissue Cytosol Nucleosol Cytosol Nucleosol Cytosol
Normal male 1 500(3.16 x 10-9) 78(9.90 x 10-10) negative negative 2.69
Normal male 2 139(1.30 x 10-9) 140(8.70 x 101-) negative negative 3.10
Normal female 1 180(1.70x 10-9) 96(l.12x 101-) negative negative 3.97
Normal female 2 28(8.62 x 10-9) 34(1.48 x 10-8) negative negative 1.52
Pooled foetal
sample 93(1.55 x 10-9) negative 29(2.90 x l0-9) negative 0.83
Case 1 45(3.64x 1O-10) 95(7.69x 1O-10) 57(3.73x 1010) 57(1.43x 10-9) 2.36
Case 2 95(3.26 x 10-9) 176(2.15 x 10-9) 144(6.29 x 101-) 23(8.06 x 10-10) 1.66
Case 3 103(6.02 x 10-10) 131(8.33 x 10-10) 370(l.26 x 10-9) 193(4.15 x 10-10) 2.22
Case 4 positive* positive* 118(1.19 x 10-9) 126(1.27 x 10-9) 1.96
Case 5 290(2.84 x 10-9) 62(6.49 x O-10) negative negative 0.76
Cavernous
haemangioma negative negative negative negative 0.82
*Insufficient tissue for full Scatchard analysis.
tested, with the exception of the cavernous
haemangioma and the foetal liver nucleosol,
contained ER (Table II and Figures 1 and 2). The
dissociation constants (Kd) and the amounts of
steroid bound per mg soluble protein were similar
to those obtained in the control samples of pre-
menopausal uterus (37-300fmolmg-1 soluble
protein. Kd 5.5x 10-8-1.2x 10-9moll-1).
In contrast, androgen receptor was found only in
the cytosol and nucleosol of the 4 samples of HCC
tested and in foetal liver cytosol (Table II and
Figures 1 and 2). Again Kd values and levels of
AR were similar to those found in the control
tissue, hypertrophied prostate (45-270fmolmg-
soluble protein. Kd 1.6-4.2 x 10 -9molI-l).
No ER or AR activity could be detected in any
sample after heat denaturation at 37°C for 30min
in the presence of CaC12. SHBG was detected in all
samples of hepatic cytosol tested in amounts
ranging from 0.76 (hepatoblastoma) to 3.97nmol
DHT boundI1 (normal female 1), but not in the
samples of hepatic nucleosol, whereas HSA-type
non specific binding was present in both the
nucleosol and cytosol of all the samples tested,
except foetal cytosol, where an unusual biphasic
pattern of binding for both DHT and E2 (distinct
from their respective binding AR, ER, SHBG and
HSA) was demonstrated (Wilkinson et al., In
press).
Discussion
High endogenous levels of steroids in the liver
make the detection of receptors difficult as ligand
binding assays do not detect occupied binding sites;
hence the need to treat preparations of cytosol and
nucleosol with dextran-coated charcoal (DCC).
Without this, high affinity specific binding was
detected in only two samples of nucleosol and one
of cytosol. Since DCC also removes NADP and
NADPH, the essential co-factors for the activities
of 5a-reductase and aromatase enzyme systems, the
high steroid metabolising enzyme activity in the
liver, which can also constitute a problem with the
assay (Aten et al., 1978; Marr et al., 1980) is also
overcome.
In previous work on rat liver other difficulties of
ER estimation in this organ have been discovered
(Wrange et al., 1980; Dickson et al., 1978). By
using a 1.215 M (NH4)2S04 precipitate true ER can
be distinguished from E2 binding sites which have a
moderate affinity and specificity in the male rat
liver cytosol. In this study, Wrange et al! (1980)
also report interference in ER analysis from a
different oestrogen binding component. The assay
employed here for AR and ER determinations
minimises the interference from competing macro-
molecules.
It is known that cytosolic ER is translocated to
the nucleus only following interaction with an
oestrogenic steroid. The presence of both cytosolic
and nucleosolic receptors is more suggestive that
ER is functional than the presence of cytosolic
receptor alone. The finding of ER in all hepatocyte
samples tested but not in the non-hepatocyte
control tissue supports the evidence referred to
earlier that oestrogenic effects on human liver are794 M.J. IQBAL et al.
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Figure 1 Scatchard plots of sex steroid binding in the cytosol and nucleosol of hepatocellular carcinoma
(case 3). tissue. Androgen receptors were assayed using methyltrienolone (R1881) as ligand and oestrogen
receptors using oestradiol (E). Sex hormone binding globulin (SHBG) and the unsaturable binding of human
serum albumin (HSA) were measured using 5a-dihydrotestosterone.
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Figure 2 Scatchard plots of oestrogen receptor binding in cytosol and nucleosol of hepatoblastoma tissue
with oestradiol (E2) as ligand. Sex hormone binding globulin (SHBG) and human serum albumin (HSA)
binding were assayed using 5a-dihydrotestosterone as ligand. Scatchard plot of oestrogen receptor (ER) and
androgen receptor (AR) in foetal liver cytosol using E2 and methyltrienolone (R1881) as ligands.
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receptor-mediated. The absence of measurable
nucleosolic ER in foetal liver may reflect low foetal
steroid levels, non-functioning receptors or
increased steroid binding to other binding proteins.
Although binding of E2, DHT and progesterone
to rat liver microsomes with moderate affinity has
been demonstrated by Yamada & Mijayi (1982),
like skeletal muscle which has a very limited ability
to bind DHT (Mainwaring & Mangan, 1973; Krieg
et al., 1974), high affinity binding of androgens has
not been demonstrated for liver. Indeed, rat liver
has been used as a negative control for AR
estimations in the male accessory sexual organs.
The lack of AR in normal adult human liver
reported here supports these findings and is
evidence against transcription of RNA from DNA
following receptor occupation and nuclear
translocation as the mechanism of androgen action
(Mainwaring, 1977).
This is surprising considering the known
androgenic effects on protein anabolism and the
prime role of the liver in protein synthesis. SHBG,
which is probably synthesised in the liver (the
relatively high levels of intracellular SHBG in liver
cytosols (Table II) compared with other tissues
(Greenway et al., 1981; Cowan et al., 1976),
supporting this view), provides an interesting
example in that circulating SHBG levels are known
to be under androgenic, as well as oestrogenic
control (Vermeulen, 1977). On current evidence it
seems likely that the effects of androgens on the
normal adult human liver are mediated by the
inherent antagonism of androgens for oestrogens or
via receptor-independent phenomena. Certain
parallels can be found with the binding of
progesterone by the hepatic endoplasmic reticulum
in the female rat (Drangova & Feuer, 1980), where
the binding of 3H progesterone by microsomes
represents a direct association without the
involvement of a cytosol receptor and transfer
process. However, this is not unexpected in that
progesterone is mainly metabolised by hepatic
microsomes.
Regarding the finding of androgen receptor in
HCC tissue as well as in foetal liver; firstly, the
protein exhibiting the high affinity binding to
methyltrienolone cannot be SHBG as SHBG does
not bind to this synthetic steroid. Secondly, the
presence of hepatic AR,-,in both these tissues may
represent foetal gene derepression, analogous to the
situation with AFP. However, the hepatoblastoma
which showed the highest serum levels of AFP did
not display AR, while the liver of case 3 with no
AFP detectable in the serum had the highest levels
of AR. Thus if gene derepression is the mechanism
for AR expression, it is independent of any such
derepression involving AFP.
The presence of similar levels of ER in both
normal and malignant liver tissue is in agreement
with a previous study of liver cytosols (Friedman,
1982), where partial, short-term remission in two
female patients was reported following progestagen
therapy. However, the presence of AR in malignant
and foetal, but not in normal adult liver tissue does
point to the possibility that HCC may be an
androgen-responsive tumour; further work is
required to establish the precise rple of sex-steroids
in this disease.
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